• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    India Closed System Drug Transfer Device Market

    ID: MRFR/Pharma/47920-HCR
    200 Pages
    Rahul Gotadki
    October 2025

    India Closed System Drug Transfer Device Market Research Report By Type (Membrane-to-membrane, Needleless System), By Component (Vial Access Devices, Syringe Safety Devices, Accessories, Bag/Line Access Devices), By Closing Mechanism (Push to Turn System, Color-to-color Alignment System, Leur Lock Systems, Click to Lock Systems), By Technology (Compartmentalize Devices, Diaphragm-Based Devices, Air Filtration Devices), and By End-users (Hospitals & Clinics, Specialty Centers, Others)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    India Closed System Drug Transfer Device Market Infographic
    Purchase Options

    India Closed System Drug Transfer Device Market Summary

    The India Closed System Drug Transfer Device market is projected to grow significantly from 48 USD Million in 2024 to 621 USD Million by 2035.

    Key Market Trends & Highlights

    India Closed System Drug Transfer Device Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate of 26.21 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 621 USD Million, indicating robust growth potential.
    • In 2024, the market is valued at 48 USD Million, reflecting the current demand for closed system drug transfer devices in India.
    • Growing adoption of closed system drug transfer devices due to increasing safety concerns in healthcare settings is a major market driver.

    Market Size & Forecast

    2024 Market Size 48 (USD Million)
    2035 Market Size 621 (USD Million)
    CAGR (2025-2035) 26.21%

    Major Players

    NeoMed, C.R. Bard, Hospira, Raumedic, Smiths Medical, Baxter International, West Pharmaceutical Services, Fresenius Kabi, Cardinal Health, B. Braun Melsungen, Terumo, Vyaire Medical, Pall Corporation, Merck KGaA

    India Closed System Drug Transfer Device Market Trends

    The market for closed system drug transfer devices in India is now expanding significantly due to a growing emphasis on patient safety and preventing drug contamination in medical facilities. Closed system drug transfer devices (CSTD) are in high demand due to growing awareness of the dangers of handling hazardous medications, especially in critical care and chemotherapy settings.

    Other important market drivers include government programs targeted at raising patient safety and healthcare infrastructure requirements. Hospitals and pharmacies are using CSTD in order to adhere to the stricter safety rules that are being implemented in the Indian healthcare industry.

    The fast growing pharmaceutical industry in India offers a wealth of prospects. Closed system drug transfer devices benefit greatly from the industry's expansion, which is fueled in part by the rise in healthcare professionals and improved treatment procedures.

    As more healthcare facilities and hospitals seek to reduce risks and enhance patient outcomes, manufacturers have the opportunity to develop and launch cutting-edge products designed for this niche market.

    Drug transfer devices are increasingly incorporating technology, according to recent trends. In addition to manufacturers concentrating on developing more user-friendly and effective designs, digital features that facilitate tracking and record-keeping are becoming more and more common.

    Additionally, there is a slow transition to sustainability with a focus on reusable parts, which reflects healthcare professionals' increasing environmental responsibility consciousness. As these trends develop, technological innovation and a dedication to improving safety procedures in healthcare delivery are expected to drive the India Closed System Drug Transfer Device Market's ongoing growth.

    Market Segment Insights

    Closed System Drug Transfer Device Market Type Insights

    The India Closed System Drug Transfer Device Market, categorized under the Type segment, is witnessing significant developments primarily due to the rising need for effective and safe methods for drug administration in healthcare settings.

    Among the types, Membrane-to-membrane systems are gaining traction due to their effectiveness in preventing contamination and enhancing the safety of drug transfer processes. These systems utilize specific membranes to protect both the drug and healthcare personnel from potential exposure to hazardous substances.

    As hospitals increasingly prioritize safety protocols to minimize risks associated with drug handling, Membrane-to-membrane systems stand out due to their efficient design, which reinforces this market's growth.

    On the other hand, Needleless Systems are also making notable strides within the market. These systems serve as a critical innovation aimed at eliminating the use of needles during drug transfer, significantly reducing the risk of needlestick injuries.

    Given the growing emphasis on patient safety and the reduction of biological hazards in medical environments, Needleless Systems presents an attractive alternative for healthcare providers. This aligns with India's healthcare policies, which increasingly advocate for practices that prioritize both patient and healthcare worker safety.

    Closed System Drug Transfer Device Market Component Insights

    The Component segment of the India Closed System Drug Transfer Device Market has been experiencing robust growth driven by increasing awareness of safety and the need for reducing hazardous drug exposure among healthcare professionals.

    Vial Access Devices play a significant role in enhancing the efficiency of drug dispensing while ensuring the integrity of the solution, which is crucial for patient safety. Syringe Safety Devices have gained traction due to their ability to minimize the risk of needlestick injuries, a common concern in Indian healthcare settings.

    Accessories, though smaller in market size, provide essential support to ensure that the devices function effectively and safely, further enhancing their importance. Bag/Line Access Devices are vital in facilitating seamless drug administration while reducing the risk of contamination.

    The collective growth of these components is being propelled by the increasing number of oncology and chemotherapy treatments in India, prompting healthcare facilities to invest in advanced closed-system drug transfer solutions. The segment is also benefiting from regulatory support aimed at improving patient outcomes and ensuring safe handling practices.

    Overall, the Component segment is positioned to contribute significantly to the advancement of drug delivery systems in the Indian healthcare market.

    Closed System Drug Transfer Device Market Closing Mechanism Insights

    The Closing Mechanism segment of the India Closed System Drug Transfer Device Market plays a crucial role in ensuring safety and efficacy in drug delivery systems. The market is characterized by various mechanisms that cater to the unique needs of healthcare providers and patients.

    One prominent type, the Push to Turn System, is praised for its intuitive operation, minimizing the risk of user error in critical environments. Meanwhile, the Color-to-color Alignment System has gained traction due to its visual cues, enhancing confidence during drug preparation and administration.

    Leur Lock Systems are widely recognized for their secure connections, thereby reducing the chances of leaks and contamination, which is a significant concern in pharmaceutical practices. Additionally, Click to Lock Systems provide a satisfying tactile feedback, assuring caregivers of a secure fit, which is vital when handling hazardous drugs.

    The increasing regulatory emphasis on safety in drug delivery and the rising adoption of connected healthcare solutions in India are driving innovation and adoption within this segment. With the expanding healthcare infrastructure and growing investments in biotechnology, these mechanisms are expected to become even more integral to the evolving landscape of drug transfer devices in India.

    Closed System Drug Transfer Device Market Technology Insights

    The India Closed System Drug Transfer Device Market, particularly in the Technology segment, showcases significant growth and development potential driven by advancements in safety and efficiency in drug handling. Compartmentalize Devices are widely recognized for their ability to minimize the risk of contamination, making them a preferred choice in healthcare settings.

    Diaphragm-Based Devices play a crucial role due to their unique design that prevents leaks and ensures secure transfer, aligning with stringent regulatory standards in the pharmaceutical industry. Air Filtration Devices are essential in maintaining a sterile environment, vital for the administration of hazardous drugs, hence they are gaining traction amid increasing focus on worker safety and environmental concerns.

    Overall, the Technology segment is marked by continuous innovations, ensuring that each device type effectively meets the growing demands of the India Closed System Drug Transfer Device Market, driven by enhanced focus on patient safety and compliance with regulatory frameworks.

    Closed System Drug Transfer Device Market

    The India Closed System Drug Transfer Device Market is showing a structured growth trajectory across various End-users, notably within Hospitals and Clinics, Specialty Centers, and others. Hospitals and Clinics dominate this arena due to their immediate need for safe and efficient drug transfer systems, driven by an increase in complex drug therapies and heightened safety awareness.

    Specialty Centers also play a pivotal role, as they often cater to patients requiring high-risk medications, necessitating the adoption of closed systems to minimize contamination and enhance patient safety. This segment growth is further propelled by stringent regulatory guidelines and a growing emphasis on patient-centric care within the healthcare framework of India.

    The evolving healthcare infrastructure, backed by government initiatives to improve access to advanced therapeutic options, is creating a robust ecosystem for closed-system devices.

    Moreover, the need for operational efficiency and the rising prevalence of chronic diseases are contributing to the expansion of this market segment, marking it as a significant focus area for technological advancements and investments in the Indian healthcare landscape.

    Get more detailed insights about India Closed System Drug Transfer Device Market

    Key Players and Competitive Insights

    The India Closed System Drug Transfer Device Market is a dynamic sector characterized by an increasing focus on safety and efficiency in drug handling within healthcare facilities. The competitive landscape is shaped by several factors including technological advancements, regulatory compliance, and the growing awareness of the risks associated with improper handling of hazardous drugs.

    With the rising incidence of healthcare-associated infections and the heightened emphasis on worker safety, manufacturers are continuously innovating to enhance the functionality and reliability of their products. The market is also influenced by collaborations, partnerships, and acquisitions, which are a modus operandi for many players aiming to expand their reach and share in this burgeoning market.

    NeoMed has established a significant presence in the India Closed System Drug Transfer Device Market by focusing on the development of advanced drug delivery systems that ensure the safety of healthcare workers and patients alike.

    The company's offerings are characterized by their innovative design, which minimizes the risk of contamination and exposure, thus catering to the growing demand for safer handling of hazardous drugs. NeoMed’s strengths lie in its commitment to research and development, ensuring that its products are aligned with international safety standards and regulations.

    The company is recognized for its exceptional customer service and support, fostering strong relationships with healthcare facilities across India, which bolsters its competitive advantage in this market. C.R. Bard has carved a niche for itself within the Indian Closed System Drug Transfer Device Market through a portfolio of products that emphasizes patient safety and operational efficiency.

    Their key products cater to the specialized needs of various healthcare professionals dealing with oncology and other hazardous drug administrations, and they are known for their rugged design and reliability.

    C.R. Bard’s strengths are underscored by its extensive distribution network and partnerships with local healthcare providers, allowing for widespread access to its innovative solutions. Additionally, the company's commitment to continuous improvement and investment in cutting-edge technologies further solidifies its market standing.

    The recent mergers and acquisitions have enhanced their capabilities, enabling them to integrate advanced technologies and expand their range of offerings to meet evolving market demands in India effectively.

    Key Companies in the India Closed System Drug Transfer Device Market market include

    Industry Developments

    The India Closed System Drug Transfer Device Market has recently witnessed several developments, with a growing emphasis on safety and efficiency in drug handling. Notably, companies such as NeoMed and C.R. Bard are advancing their product lines to meet the increasing demand for safe drug administration, thereby enhancing their market presence.

    In terms of mergers and acquisitions, a significant event occurred in March 2023 when Baxter International acquired a stake in a local innovation firm, aiming to expand its capabilities in closed system devices. Similarly, West Pharmaceutical Services in January 2023 announced a collaboration with Indian manufacturers to improve distribution efficiency across the region.

    The market is projected to grow steadily, bolstered by the increasing incidence of hazardous drug exposure among healthcare workers, leading to a surge in demand for closed-system transfer devices. Recent government initiatives aimed at improving healthcare infrastructure further enhance the growth potential, as the Ministry of Health and Family Welfare launches programs promoting safety in medication administration.

    Over the past few years, substantial investments have been made in Research and Development by companies like Fresenius Kabi and Cardinal Health to innovate and expand their offerings in this critical healthcare segment in India.

    Market Segmentation

    Outlook

    • Hospitals & Clinics
    • Specialty Centers
    • Others

    Closed System Drug Transfer Device Market Type Outlook

    • Membrane-to-membrane
    • Needleless System

    Closed System Drug Transfer Device Market Component Outlook

    • Vial Access Devices
    • Syringe Safety Devices
    • Accessories
    • Bag/Line Access Devices

    Closed System Drug Transfer Device Market End-users Outlook

    • Hospitals & Clinics
    • Specialty Centers
    • Others

    Closed System Drug Transfer Device Market Technology Outlook

    • Compartmentalize Devices
    • Diaphragm-Based Devices
    • Air Filtration Devices

    Closed System Drug Transfer Device Market Closing Mechanism Outlook

    • Push to Turn System
    • Color-to-color Alignment System
    • Leur Lock Systems
    • Click on Lock Systems

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 42.8(USD Million)
    MARKET SIZE 2024 48.0(USD Million)
    MARKET SIZE 2035 621.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 26.205% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED NeoMed, C.R. Bard, Hospira, Raumedic, Smiths Medical, Baxter International, West Pharmaceutical Services, Fresenius Kabi, Cardinal Health, B. Braun Melsungen, Terumo, Vyaire Medical, Pall Corporation, Merck KGaA
    SEGMENTS COVERED Type, Component, Closing Mechanism, Technology, End-Users
    KEY MARKET OPPORTUNITIES Rising cancer treatments demand, Increasing awareness of safety protocols, Growth of home healthcare services, Government regulations on drug handling, Advancements in medical technology.
    KEY MARKET DYNAMICS rising demand for chemotherapy, increasing healthcare expenditures, stringent safety regulations, technological advancements, growing awareness of occupational hazards
    COUNTRIES COVERED India

    FAQs

    What is the expected market size of the India Closed System Drug Transfer Device Market in 2024?

    The India Closed System Drug Transfer Device Market is expected to be valued at 48.0 USD Million in 2024.

    What will the market size of the India Closed System Drug Transfer Device Market be by 2035?

    By 2035, the market is anticipated to reach a valuation of 621.0 USD Million.

    What is the expected compound annual growth rate (CAGR) for the market from 2025 to 2035?

    The expected CAGR for the India Closed System Drug Transfer Device Market is 26.205% during the forecast period from 2025 to 2035.

    What are the key competitors in the India Closed System Drug Transfer Device Market?

    Some major players in the market include NeoMed, C.R. Bard, Hospira, and Baxter International.

    How is the market segmented by type in the India Closed System Drug Transfer Device Market?

    The market is primarily divided into 'Membrane to Membrane' and 'Needleless System' segments.

    What is the market value for the Membrane to Membrane type in 2024?

    The Membrane to Membrane segment is valued at 18.0 USD Million in 2024.

    What is the projected value for the Needleless System segment by 2035?

    The Needleless System segment is expected to reach a valuation of 368.4 USD Million by 2035.

    What are the growth drivers for the India Closed System Drug Transfer Device Market?

    Increased healthcare expenditures and the rising demand for safety in drug handling are key growth drivers for the market.

    What challenges does the India Closed System Drug Transfer Device Market currently face?

    Challenges in the market include high competition and stringent regulatory requirements impacting entry barriers.

    How does the current global scenario potentially impact the India Closed System Drug Transfer Device Market?

    The global scenario may create fluctuations in supply chain dynamics and affect market stability in the India Closed System Drug Transfer Device Market.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials